Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. - Wikidata - awgldk - TriplyDB

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

http://www.wikidata.org/entity/Q33716280

about

Polymeric micelles for multi-drug delivery in cancer Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics Multifunctional polymeric micelles for delivery of drugs and siRNA.Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment.Nanocarriers for delivery of platinum anticancer drugs.Self-assembled micelles based on pH-sensitive PAE-g-MPEG-cholesterol block copolymer for anticancer drug delivery Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics Targeted delivery of platinum-taxane combination therapy in ovarian cancer.Recent advances of cocktail chemotherapy by combination drug delivery systems.A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics.Classification of stimuli-responsive polymers as anticancer drug delivery systems.Polymeric nanoparticles: the future of nanomedicine.Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation Multifunctional platinum-based nanoparticles for biomedical applications.Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer.Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2.Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.

P2860

Q27025861-6A12A5E6-60B9-4B95-948C-F57C61C89789 Q30421664-CE4E4365-2CE7-4198-A3CE-E9B6268B4BB4 Q30438973-E89361C9-03BF-4963-A467-70EFBB4BE27B Q33742311-C116F08F-B094-420E-B9C6-758520E520B4 Q34338695-6195C996-F444-467D-9AEB-30B460160FA2 Q34415598-CA2A1545-ED6C-4C7B-802E-F486DD668253 Q34440323-A5F737FA-487E-45A9-9B81-CE0A71FD3B9B Q35032561-9C386841-F524-455C-9A83-9BD431E0C8CA Q35602561-B271D451-BFDB-43FD-880A-72B43A13866F Q36035550-6EE603C2-6687-4860-BD74-F2C9FF68848F Q36395811-4B1F2D87-0458-42F4-8D27-30E8A98347F8 Q37206908-0FC44E9B-F6B0-4F0B-8D0E-F83EB012C836 Q37619943-DD74E223-9289-4E60-8E89-72D5B3C523BB Q38189091-53E75D57-9AB2-4140-9447-2761F3E1C4C1 Q38575282-1B2C2EFE-9186-4B3D-B7C9-8AC5F0D062ED Q38634048-1AAF668D-0DB4-4F77-932D-D35A52267951 Q38812240-BCE5A298-0785-46B6-ACF7-B753166F0B51 Q38896198-E8FB9C3E-1474-469B-8C9C-0FA994B37121 Q49797582-49FEEC9D-4A36-4577-A73D-3FC3DEF05BF9 Q53276308-D112B353-B3DF-44D4-871F-82C4C13EA9BD Q55018323-6B1F0A43-2030-47B1-9F3E-82A4650FC214

P2860

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

http://www.wikidata.org/entity/Q33716280

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

@ast

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

@en

type

label

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

@ast

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

@en

prefLabel

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

@ast

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

@en

P1433

Q33716280-8B4A1394-E138-4B74-852E-21F19DAF0681

P1476

Q33716280-AA60B69D-157C-4FFA-816A-8FB8753058B7

P2093

Q33716280-253D38B1-3E3D-4ABB-AEF8-345866AE1E15

Q33716280-8C34B613-A879-44F3-ABE7-C05258AABE14

Q33716280-C14CEADE-FEFC-4536-8CBE-462A96BB963D

Q33716280-EFDFD6F7-4E45-4626-8358-CD218406E365

P2860

Q33716280-00708E10-AE50-4617-84F7-7630A97DFF8C

Q33716280-08F847F8-828D-4663-AF6B-577876A27D38

Q33716280-34F5518D-482A-4894-9F2D-EA2425D844A8

Q33716280-44CA53F2-45D1-4028-99CF-8565667924F6

Q33716280-455485B6-0330-43AA-860E-4C29A2C22B31

Q33716280-56975B02-C7B7-45C8-8164-41A0E3F92141

Q33716280-5D159CC2-1EDE-4686-9C9E-8DB83D1C18FD

Q33716280-606340DC-C147-4553-9DD5-651D4D0E2D7A

Q33716280-626AE91A-31A0-4503-A429-A5BD9ABE39B0

Q33716280-6B3A397B-1988-45EC-AEAD-32AD826977FD

P304

Q33716280-5B54E080-8D46-4783-9875-08E3D40E77DF

P31

Q33716280-827EE605-D912-468D-AEB8-1C526352ADC5

P356

Q33716280-1C0A2E84-EF46-4B86-858E-A0D432FA5E1F

P407

Q33716280-73C9FFB5-FF01-4BCB-865C-B3AC7758AC06

P433

Q33716280-7BB941EF-1206-4F59-8FE8-6F71B89CF2C2

P478

Q33716280-C72B3A49-BF1A-482D-BA82-E538EF417D43

P50

Q33716280-2DA7A0D5-D937-482B-A660-ED94BEDAB3F9

P577

Q33716280-C2A4793A-151E-419D-A81A-1BD3E21AE401

P5875

Q33716280-26915728-39E8-491E-AE7F-D4E47617E2D1

P698

Q33716280-0EDB34CE-1692-4D5D-BB54-0CDA57F1A6E4

P921

Q33716280-7AF47ECA-FEAB-4566-85C4-C23CC4BAC84B

Q33716280-85F7B31A-64DB-440B-A207-EBF52C0CDDAC

Q33716280-F52AB5DC-9F96-4ED5-93BC-D343FF977B04

P932

Q33716280-8EBD5C3A-EAD8-40BB-BDD7-2324C22D3B50

P356

J.JCONREL.2013.04.026

P1433

Journal of Controlled Release

P1476

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer

@en

P2093

Samuel M Cohen

http://www.w3.org/2001/XMLSchema#string

Swapnil S Desale

http://www.w3.org/2001/XMLSchema#string

Tatiana K Bronich

http://www.w3.org/2001/XMLSchema#string

Yi Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

The status of platinum anticancer drugs in the clinic and in clinical trials

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Drug combination studies and their synergy quantification using the Chou-Talalay method

Direct formation of giant vesicles from synthetic polypeptides.

The biology of ovarian cancer: new opportunities for translation

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin.

Unraveling the role of proteases in cancer.

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.

Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticles

Polyelectrolyte Nanogels Decorated with Monoclonal Antibody for Targeted Drug Delivery.

P304

339-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2013.04.026

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236691104

http://www.w3.org/2001/XMLSchema#string

P698

23665258

http://www.w3.org/2001/XMLSchema#string

P921

P932

4046853

http://www.w3.org/2001/XMLSchema#string